Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

FAM188A Activators

FAM188A Activators are a diverse array of chemical compounds that indirectly promote the functional activity of FAM188A through modulation of various signaling pathways and cellular processes. Forskolin and Rolipram both act by inhibiting the degradation of cAMP, with the former directly stimulating adenylate cyclase and the latter inhibiting phosphodiesterase-4. Elevated cAMP levels result in the activation of PKA, which could potentially phosphorylate FAM188A, thereby enhancing its functional activity. Similarly, Dibutyryl-cAMP, a synthetic analog of cAMP, directly activates PKA leading to the same outcome for FAM188A. Ionomycin and Phorbol 12-myristate 13-acetate (PMA) exert their effects through the modulation of intracellular calcium and activation of PKC, respectively, both of which may lead to the phosphorylation and subsequent activation of FAM188A. Sphingosine-1-phosphate (S1P) and Anisomycin engage with specific receptor-mediated pathways and stress-activated protein kinases, such as JNK, that could also facilitate the phosphorylation and enhancement of FAM188A's activity.

Further influencing the activity of FAM188A, compounds like Epigallocatechin Gallate (EGCG) and Zaprinast function by inhibiting various kinases and phosphodiesterases, thereby potentially relieving FAM188A from negative regulatory constraints and enhancing its activity. LY294002, U0126, and SB203580 indirectly contribute to FAM188A activation by modulating PI3K, MEK1/2, and p38 MAPK signaling pathways, respectively, which might reduce inhibitory signals thereby favoring pathways that lead to FAM188A activation. Collectively, these chemical activators, through their targeted effects on cellular signaling, facilitate the enhancement of FAM188A mediated functions. They do so by either promoting the activation of kinases that can directly phosphorylate FAM188A or by altering signaling pathways that reduce inhibitory influences on FAM188A, thus allowing for its enhanced activity without the need for upregulating its expression or direct activation.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

EGCG is a potent antioxidant that inhibits several protein kinases, potentially altering signaling pathways. Through kinase inhibition, EGCG may reduce negative regulatory mechanisms, indirectly enhancing the activity of FAM188A.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Ionomycin is a calcium ionophore that increases intracellular calcium concentrations, which could activate calcium-dependent kinases. These kinases may phosphorylate FAM188A, thereby enhancing its activity.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA is a diacylglycerol analog that activates protein kinase C (PKC). PKC can phosphorylate a plethora of proteins, potentially including FAM188A, to enhance its activity.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$165.00
$322.00
$570.00
$907.00
$1727.00
7
(1)

S1P activates S1P receptors, triggering downstream signaling pathways that can lead to the activation of kinases which, in turn, could phosphorylate and enhance the activity of FAM188A.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

Rolipram inhibits phosphodiesterase-4 (PDE4), leading to increased cAMP levels. This enhancement of cAMP may result in the activation of PKA, which could phosphorylate FAM188A and enhance its activity.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor that can alter downstream signaling, potentially reducing negative regulatory inputs and indirectly enhancing the signaling pathways involving FAM188A activity.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 inhibits MEK1/2, which may shift the signaling balance to favor pathways that could enhance the activity of FAM188A.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a specific inhibitor of p38 MAPK, which might lead to the activation of alternative pathways that enhance the functional activity of FAM188A.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$47.00
$136.00
$492.00
$4552.00
74
(7)

db-cAMP is a cell-permeable cAMP analog that activates PKA. PKA activation could result in the phosphorylation and enhancement of FAM188A activity.

Zaprinast (M&B 22948)

37762-06-4sc-201206
sc-201206A
25 mg
100 mg
$105.00
$250.00
8
(2)

Zaprinast inhibits PDE5, resulting in increased cAMP and cGMP levels. The increase in cyclic nucleotides can enhance the activity of PKA or PKG, which could then phosphorylate and enhance the activity of FAM188A.